Skip to content

Clinical trials

Pulmonary Disease, Chronic Obstructive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Clear all

5,322 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200026
200131
200251
200347
200477
2005104
2006124
2007151
2008177
2009221
2010207
2011248
2012239
2013226
2014262
2015228
2016274
2017293
2018227
2019270
2020205
2021246
2022225
2023271
2024286
2025280
2026241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3,325
Unknown status790
Recruiting420
Terminated286
Not yet recruiting207
Withdrawn138
Active, not recruiting107
Enrolling by invitation36
Suspended13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline275
AstraZeneca235
Boehringer Ingelheim235
Novartis Pharmaceuticals88
Chiesi Farmaceutici S.p.A.61
Riphah International University57
Imperial College London49
University of Zurich38
Pearl Therapeutics, Inc.37
VA Office of Research and Development36

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive5,322
Asthma437
Emphysema296
Dyspnea231
Heart Failure201
Lung Diseases190
Bronchitis, Chronic161
Lung Diseases, Obstructive103
Diabetes Mellitus100
Lung Diseases, Interstitial88

Trials

Showing 26 to 50 of 5,322. Each trial links to its page on Pharma Observatory.

5,222 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.